Search Results - "McLean, Pamela"
-
1
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Published in Cell (08-07-2011)“…Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked to the lysosomal storage disorder Gaucher disease (GD), but the…”
Get full text
Journal Article -
2
α-Synuclein Multimers Cluster Synaptic Vesicles and Attenuate Recycling
Published in Current biology (06-10-2014)“…The normal functions and pathologic facets of the small presynaptic protein α-synuclein (α-syn) are of exceptional interest. In previous studies, we found that…”
Get full text
Journal Article -
3
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Published in Molecular neurodegeneration (24-08-2012)“…Aggregation of alpha-synuclein (αsyn) and resulting cytotoxicity is a hallmark of sporadic and familial Parkinson's disease (PD) as well as dementia with Lewy…”
Get full text
Journal Article -
4
Protein degradation pathways in Parkinson’s disease: curse or blessing
Published in Acta neuropathologica (01-08-2012)“…Protein misfolding, aggregation and deposition are common disease mechanisms in many neurodegenerative diseases including Parkinson’s disease (PD)…”
Get full text
Journal Article -
5
Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease
Published in Annals of neurology (01-10-2019)“…Objective Excessive inflammation in the central nervous system (CNS) and the periphery can result in neurodegeneration and parkinsonism. Recent evidence…”
Get full text
Journal Article -
6
Cellular models of alpha‐synuclein toxicity and aggregation
Published in Journal of neurochemistry (01-09-2019)“…Misfolding and aggregation of alpha‐synuclein (α‐synuclein) with concomitant cytotoxicity is a hallmark of Lewy body related disorders such as Parkinson’s…”
Get full text
Journal Article -
7
Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
Published in Molecular neurodegeneration (13-01-2020)“…Misfolding and aggregation of the presynaptic protein alpha-synuclein (αsyn) is a hallmark of Parkinson's disease (PD) and related synucleinopathies. Although…”
Get full text
Journal Article -
8
SIRT1 protects against α-synuclein aggregation by activating molecular chaperones
Published in The Journal of neuroscience (04-01-2012)“…α-Synuclein is a key molecule in the pathogenesis of synucleinopathy including dementia with Lewy bodies, Parkinson's disease, and multiple system atrophy…”
Get full text
Journal Article -
9
Biomarkers in Parkinson's disease: Advances and strategies
Published in Parkinsonism & related disorders (01-01-2016)“…Abstract Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive motor disturbances and affects more than 1% of the worldwide…”
Get full text
Journal Article -
10
Formation of toxic oligomeric alpha-synuclein species in living cells
Published in PloS one (02-04-2008)“…Misfolding, oligomerization, and fibrillization of alpha-synuclein are thought to be central events in the onset and progression of Parkinson's disease (PD)…”
Get full text
Journal Article -
11
α-Synuclein oligomers and clinical implications for Parkinson disease
Published in Annals of neurology (01-02-2013)“…Protein aggregation within the central nervous system has been recognized as a defining feature of neurodegenerative diseases since the early 20th century…”
Get full text
Journal Article -
12
Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates
Published in Scientific reports (09-08-2017)“…In neurodegenerative diseases, seeding is a process initiated by the internalization of exogenous protein aggregates. Multiple pathways for internalization of…”
Get full text
Journal Article -
13
Chaperones in Neurodegeneration
Published in The Journal of neuroscience (14-10-2015)“…Cellular protein homeostasis (proteostasis) maintains the integrity of the proteome and includes protein synthesis, folding, oligomerization, and turnover;…”
Get full text
Journal Article -
14
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein
Published in The Journal of neuroscience (12-10-2011)“…Increased intracellular levels of α-synuclein are implicated in Parkinson's disease and related disorders and may be caused by alterations in the…”
Get full text
Journal Article -
15
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Published in Journal of neuropathology and experimental neurology (01-12-2008)“…Microglial activation and adaptive immunity have been implicated in the neurodegenerative processes in Parkinson disease. It has been proposed that these…”
Get full text
Journal Article -
16
Optimizing SH-SY5Y cell culture: exploring the beneficial effects of an alternative media supplement on cell proliferation and viability
Published in Scientific reports (27-02-2024)“…In the quest to unravel the mysteries of neurological diseases, comprehending the underlying mechanisms is supreme. The SH-SY5Y human neuroblastoma cell line…”
Get full text
Journal Article -
17
Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5)
Published in PloS one (16-02-2011)“…Parkinson's disease (PD) is a common neurodegenerative condition in which abnormalities in protein homeostasis, or proteostasis, may lead to accumulation of…”
Get full text
Journal Article -
18
CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
Published in Nature communications (03-01-2019)“…CRISPR/Cas9 guided gene-editing is a potential therapeutic tool, however application to neurodegenerative disease models has been limited. Moreover,…”
Get full text
Journal Article -
19
Alpha-synuclein and tau: teammates in neurodegeneration?
Published in Molecular neurodegeneration (29-10-2014)“…The accumulation of α-synuclein aggregates is the hallmark of Parkinson's disease, and more generally of synucleinopathies. The accumulation of tau aggregates…”
Get full text
Journal Article -
20
Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease
Published in Gut microbes (01-01-2021)“…Parkinson's disease (PD) is a common neurodegenerative disorder characterized primarily by motor and non-motor gastrointestinal (GI) deficits. GI symptoms'…”
Get full text
Journal Article